Skip Ribbon Commands
Skip to main content
Sign In
{{'GLOBAL_MESSAGE_HEADLINE' | translate}}
{{'GLOBAL_MESSAGE_CHOOSE_LANG' | translate}}
en
日本語
中文
{{'GLOBAL_MESSAGE_OR' | translate}}
{{'GLOBAL_MESSAGE_SET_COUNTRY' | translate}}
{{'ELOQUA_BANNER_DECLINE_CONFIRM' | translate}}
{{'ELOQUA_BANNER_DECLINE_CONFIRM_CLOSE' | translate}}
{{'ELOQUA_BANNER_ACCEPT' | translate}}
{{'ELOQUA_BANNER_DECLINE' | translate}}

​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​

LATEST NEWS

The Spectra Optia® Apheresis System from Terumo Blood and Cell Technologies in combination with UVA PIT System can now be used to provide extracorporeal photopheresis immunotherapy

Terumo Blood and Cell Technologies Joins Cell and Gene Therapy Catapult Process Analytical Technology (PAT) Consortium

Terumo Blood and Cell Technologies announces participation in the Connecting the Dots video series, highlighting advanced medical therapies

Blood Centers of America Recognizes Outstanding Partners During the COVID-19 Pandemic With Critical Infusion Award

Asia Pacific Advanced Therapy Manufacturing & Innovation (ATMI) Grant Winner From Seoul National University College Announced by Terumo Blood and Cell Technologies

Terumo Blood and Cell Technologies Grants $50,000 to Support Blood Donor Education Program

Convalescent Plasma - An Approach to COVID-19

Lakewood Action Center Set to Provide Grocery Boxes for 5,700 Meals This Thanksgiving

Coalition Set Up to Find Solutions to the Challenge of Safe, Sustainable and Adequate Blood in Africa

Terumo Blood and Cell Technologies Joins Cell Manufacturing Research Initiative to Help Advance Cell Therapy Discoveries

{{'SEARCH_MODAL_TITLE' | translate }}
{{'SEARCH_MODAL_OR' | translate }}

{{'SEARCH_MODAL_BROWSE' | translate }}
{{'SEARCH_MODAL_CHOOSE_LANGUAGE' | translate }} {{'SEARCH_MODAL_CHANGE_LANGUAGE' | translate }}
{{$index+1}}. {{s.label}}